|
|
Volumn 114, Issue 2, 2007, Pages 400-
|
|
Intravitreal Bevacizumab
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
BLOOD VESSEL PERMEABILITY;
COST EFFECTIVENESS ANALYSIS;
DRUG CONTAMINATION;
DRUG COST;
DRUG LEGISLATION;
DRUG STORAGE;
ENDOPHTHALMITIS;
EXPIRATION DATE;
GOVERNMENT REGULATION;
HUMAN;
LETTER;
METHODOLOGY;
PRIORITY JOURNAL;
RETINA MACULA DEGENERATION;
RETINA NEOVASCULARIZATION;
SHELF LIFE;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CHOROIDAL NEOVASCULARIZATION;
DRUG COMPOUNDING;
HUMANS;
INJECTIONS;
MACULAR DEGENERATION;
TOMOGRAPHY, OPTICAL COHERENCE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
VITREOUS BODY;
|
|
EID: 33846486692
PISSN: 01616420
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ophtha.2006.10.002 Document Type: Letter |
|
Times cited : (3)
|
|
References (3)
|
